General medicine - private practice in სამგორის რაიონი, ქ. თბილისი. Address: საქართველო, თბილისი, სამგორის რაიონი, ფრანგულიანის ქ., №19.
Subsidiary of Shezghuduli (100.0%)
| Ratio | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Margins | ||||
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% |
| EBITDA Margin | 36.8% | 14.7% | -16.0% | -12.4% |
| EBITDAR | 662 | 115 | -33 | -23 |
| EBITDAR Margin | 36.8% | 14.7% | -16.0% | -12.4% |
| EBIT Margin | 36.1% | 12.2% | -24.3% | -27.0% |
| Net Profit Margin | 36.1% | 12.2% | -501.6% | 295.7% |
| Operating Expense % of Sales | 63.2% | 85.3% | 116.0% | 112.4% |
| Returns | ||||
| Return on Assets (ROA) | 42.9% | 6.5% | -70.7% | 39.4% |
| Return on Equity (ROE) | 91.4% | 11.8% | N/A | 164.7% |
| ROIC [EBIT / Invested Capital] | 157.1% | 13.0% | N/A | -15.1% |
| Leverage & debt balances | ||||
| Debt-to-Assets | 0.1% | 0.2% | 0.0% | 0.0% |
| Debt-to-Equity | 0.00x | 0.00x | -0.00x | 0.00x |
| Debt-to-EBITDA | 0.00x | 0.02x | N/A | N/A |
| Equity-to-Assets | 46.9% | 54.9% | -15.1% | 23.9% |
| Net Debt | -297 | -74 | -2 | -1 |
| Cash & Equivalents | 299 | 77 | 2 | 1 |
| Total Debt | 2 | 2 | N/A | N/A |
| Liquidity & working capital | ||||
| Current Ratio | 0.47x | 0.55x | 0.15x | 0.24x |
| Quick Ratio | 0.47x | 0.55x | 0.15x | 0.24x |
| Cash Ratio | 0.20x | 0.05x | 0.00x | 0.00x |
| Total Current Assets | 710 | 806 | 218 | 337 |
| Total Current Liabilities | 1,514 | 1,466 | 1,448 | 1,410 |
| Inventory | N/A | N/A | N/A | N/A |
| Trade Receivables | 470 | 118 | 141 | 126 |
| Trade Payables | 143 | 15 | 39 | 43 |
| Net Working Capital | -804 | -661 | -1,230 | -1,073 |
| Net Working Capital % of Revenue | -44.7% | -84.6% | -602.5% | -571.4% |
| Trade Working Capital | 327 | 103 | 101 | 84 |
| Trade Working Capital % of Revenue | 18.2% | 13.2% | 49.6% | 44.6% |
| Change in Trade Working Capital | N/A | -223 | -2 | -18 |
| Turnover & efficiency | ||||
| Inventory Turnover | N/A | N/A | N/A | N/A |
| Days Inventory Outstanding (DIO) | N/A | N/A | N/A | N/A |
| Receivables Turnover | 3.82x | 6.62x | 1.45x | 1.49x |
| Days Sales Outstanding (DSO) | 95.4 | 55.2 | 251.6 | 245.6 |
| Payables Turnover | N/A | N/A | N/A | N/A |
| Days Payable Outstanding (DPO) | N/A | N/A | N/A | N/A |
| Cash Conversion Cycle | 95.4 days | 55.2 days | 251.6 days | 245.6 days |
| Asset Turnover | 1.19x | 0.53x | 0.14x | 0.13x |
| Cash flow & dividends | ||||
| Operating Cash Flow | 290 | -222 | -75 | -1 |
| Free Cash Flow (OCF − Capex proxy) | 290 | -222 | -75 | -1 |
| Cash Conversion (OCF / EBITDA) | 43.8% | -193.2% | N/A | N/A |
| Dividends Declared | N/A | N/A | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →